{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:57:53Z","timestamp":1761490673626,"version":"3.37.3"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008015","name":"Australian National Fabrication Facility","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008015","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.xphs.2018.10.029","type":"journal-article","created":{"date-parts":[[2018,10,25]],"date-time":"2018-10-25T22:53:51Z","timestamp":1540508031000},"page":"1220-1226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Bioerodable Ketamine-Loaded Microparticles Fabricated Using Dissolvable Hydrogel Template Technology"],"prefix":"10.1016","volume":"108","author":[{"given":"Minze","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew K.","family":"Whittaker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maree T.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felicity Y.","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.xphs.2018.10.029_bib1","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1089\/jpm.2010.0424","article-title":"The use of ketamine in severe cases of refractory pain syndromes in the palliative care setting: a case series","volume":"14","author":"Kerr","year":"2011","journal-title":"J\u00a0Palliat Med"},{"issue":"3","key":"10.1016\/j.xphs.2018.10.029_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3322\/caac.20112","article-title":"The management of cancer pain","volume":"61","author":"Paice","year":"2011","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.xphs.2018.10.029_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/107327480000700205","article-title":"Interventional treatment of cancer pain: the fourth step in the World Health Organization analgesic ladder?","volume":"7","author":"Miguel","year":"2000","journal-title":"Cancer Control"},{"issue":"2","key":"10.1016\/j.xphs.2018.10.029_bib4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.mcna.2006.10.015","article-title":"Interventional approaches to pain management","volume":"91","author":"Markman","year":"2007","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.xphs.2018.10.029_bib5","doi-asserted-by":"crossref","first-page":"96","DOI":"10.12688\/f1000research.2-96.v1","article-title":"Intrathecal drug delivery (ITDD) systems for cancer pain","volume":"2","author":"Bhatia","year":"2013","journal-title":"F1000Res"},{"issue":"41","key":"10.1016\/j.xphs.2018.10.029_bib6","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.2174\/138161281941131219130127","article-title":"Delivery systems of opioid analgesics for pain relief: a review","volume":"19","author":"Wojciech","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"9","key":"10.1016\/j.xphs.2018.10.029_bib7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.mattod.2016.01.016","article-title":"Controlled-release of opioids for improved pain management","volume":"19","author":"Martin","year":"2016","journal-title":"Mater Today"},{"key":"10.1016\/j.xphs.2018.10.029_bib8","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1002\/jps.24497","article-title":"Novel polymeric bioerodable microparticles for prolonged-release intrathecal delivery of analgesic agents for relief of intractable cancer-related pain","volume":"104","author":"Han","year":"2015","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2018.10.029_bib9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2147\/IJN.S40579","article-title":"Concepts and practices used to develop functional PLGA-based nanoparticulate systems","volume":"8","author":"Sah","year":"2013","journal-title":"Int J Nanomedicine"},{"issue":"3","key":"10.1016\/j.xphs.2018.10.029_bib10","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.3390\/polym3031377","article-title":"Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier","volume":"3","author":"Makadia","year":"2011","journal-title":"Polymers"},{"issue":"1-3","key":"10.1016\/j.xphs.2018.10.029_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0168-3659(98)00076-5","article-title":"Factors influencing the diffusion-controlled release of papaverine from poly (L-lactic acid) matrix","volume":"56","author":"Miyajima","year":"1998","journal-title":"J\u00a0Control Release"},{"issue":"1","key":"10.1016\/j.xphs.2018.10.029_bib12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ijpharm.2013.11.058","article-title":"Microparticles produced by the hydrogel template method for sustained drug delivery","volume":"461","author":"Lu","year":"2014","journal-title":"Int J Pharm"},{"key":"10.1016\/j.xphs.2018.10.029_bib13","series-title":"Biodegradable Polymers in Clinical Use and Clinical Development","first-page":"317","article-title":"Lactide and glycolide polymers","author":"Letchford","year":"2011"},{"issue":"2","key":"10.1016\/j.xphs.2018.10.029_bib14","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1471-4159.2011.07361.x","article-title":"Potentiation of mu-opioid receptor-mediated signaling by ketamine","volume":"119","author":"Gupta","year":"2011","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.xphs.2018.10.029_bib15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fphar.2016.00185","article-title":"Bioerodable PLGA-based microparticles for producing sustained-release drug formulations and strategies for improving drug loading","volume":"7","author":"Han","year":"2016","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.xphs.2018.10.029_bib16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2005.07.031","article-title":"How porosity and size affect the drug release mechanisms from PLGA-based microparticles","volume":"314","author":"Klose","year":"2006","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2018.10.029_bib17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jconrel.2009.09.032","article-title":"The hydrogel template method for fabrication of homogeneous nano\/microparticles","volume":"141","author":"Acharya","year":"2010","journal-title":"J\u00a0Control Release"},{"issue":"2-3","key":"10.1016\/j.xphs.2018.10.029_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0168-3659(01)00248-6","article-title":"On the importance and mechanisms of burst release in matrix-controlled drug delivery systems","volume":"73","author":"Huang","year":"2001","journal-title":"J\u00a0Control Release"},{"issue":"2","key":"10.1016\/j.xphs.2018.10.029_bib19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/cphc.200400527","article-title":"Nanoparticles and nanocapsules created using the ouzo effect: spontaneous emulsification as an alternative to ultrasonic and high-shear devices","volume":"6","author":"Ganachaud","year":"2005","journal-title":"ChemPhysChem"},{"issue":"10","key":"10.1016\/j.xphs.2018.10.029_bib20","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1021\/la026842o","article-title":"Liquid droplet dispersions formed by homogeneous liquid\u2013liquid nucleation:\u2009 \u201cthe ouzo effect.\u201d","volume":"19","author":"Vitale","year":"2003","journal-title":"Langmuir"},{"issue":"1","key":"10.1016\/j.xphs.2018.10.029_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0378-5173(88)90073-7","article-title":"Solvent selection in the preparation of poly(dl-lactide) microspheres prepared by the solvent evaporation method","volume":"43","author":"Bodmeier","year":"1988","journal-title":"Int J Pharm"},{"issue":"2","key":"10.1016\/j.xphs.2018.10.029_bib22","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijpharm.2008.04.042","article-title":"Principles of encapsulating hydrophobic drugs in PLA\/PLGA microparticles","volume":"364","author":"Wischke","year":"2008","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.xphs.2018.10.029_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0378-5173(94)90201-1","article-title":"The preparation and characterization of poly(lactide-co-glycolide) microparticles: III. Microparticle\/polymer degradation rates and the in\u00a0vitro release of a model protein","volume":"103","author":"O'Hagan","year":"1994","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.xphs.2018.10.029_bib24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.cherd.2010.06.013","article-title":"Effect of copolymer ratio on hydrolytic degradation of poly(lactide-co-glycolide) from drug eluting coronary stents","volume":"89","author":"Engineer","year":"2011","journal-title":"Chem Eng Res Des"},{"issue":"3","key":"10.1016\/j.xphs.2018.10.029_bib25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2013006475","article-title":"Poly(lactic-co-glycolic) acid-controlled release systems: experimental and modeling insights","volume":"30","author":"Hines","year":"2013","journal-title":"Crit Rev Ther Drug Carrier Syst"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918306294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918306294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T12:39:54Z","timestamp":1565267994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354918306294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0022354918306294"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2018.10.029","relation":{},"ISSN":["0022-3549"],"issn-type":[{"type":"print","value":"0022-3549"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioerodable Ketamine-Loaded Microparticles Fabricated Using Dissolvable Hydrogel Template Technology","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2018.10.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}